Skip to content
Disclosery

EXANE DERIVATIVES: REXR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on REXR, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 2,369 REXR shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 2,369 shares
    Change vs previous 13F -133 shares

    0.08% of the 13F portfolio, value $136,403.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 2,502 shares
    Change vs previous 13F +22 shares

    0.05% of the 13F portfolio, value $186,613.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 2,480 shares
    Change vs previous 13F -24 shares

    0.05% of the 13F portfolio, value $201,146.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 2,504 shares
    Change vs previous 13F +2,498 shares

    0.04% of the 13F portfolio, value $142,097.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 6 shares
    Change vs previous 13F -4 shares

    <0.01% of the 13F portfolio, value $350.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 10 shares
    Change vs previous 13F -171 shares

    <0.01% of the 13F portfolio, value $504.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 181 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $8,888.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).